Novartis

Novartis booth at AACR 2026
Biotech

Has Novartis’ T-Charge push been overtaken by in vivo CAR-Ts?

It’s been over four years since Novartis shook up the CAR-T space with its T-Charge platform. But that’s a lifetime in the world of cell therapies.
James Waldron May 22, 2026 8:28am
NVS

Novartis trims ‘select number’ of biomedical research roles

May 15, 2026 10:58am
Narasimhan

Novartis CEO ‘continuing to evaluate’ in vivo CAR-Ts

Apr 28, 2026 3:21am
Cutting branch off a tree with a chainsaw

Novartis narrows anticoagulant's focus after losing to Eliquis

Apr 22, 2026 4:00am
Narasimhan
Favicon Fierce Pharma

Novartis CEO Vas Narasimhan joins Anthropic's board

Apr 15, 2026 10:36am
Statue in Vienna of Heracles battling the hydra

The 'diabolical' molecule set to become biotech's next gold rush

Apr 9, 2026 8:00am